InvestorsHub Logo
Followers 26
Posts 1587
Boards Moderated 0
Alias Born 05/03/2012

Re: None

Tuesday, 05/14/2024 7:47:42 AM

Tuesday, May 14, 2024 7:47:42 AM

Post# of 460109
IMO . Dr. Jin and his team has been having discussions with the FDA about the new AD guidance and the path forward for Anavex.
Maybe it’s just a coincidence that after almost two years after the ph2’3 AD trial completion, Anavex finally revealed the ADCS-ADL endpoint miss at the same time the FDA dropped it from the new guidance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News